Seasonal influenza vaccination
Seasonal influenza vaccination has been studied in 1 paper since 2016: 1 trial in people. The newest paper, Mar 15, 2016: “Effect of a synbiotic on the response to seasonal influenza vaccination is strongly influenced by degree of immunosenescence”.
1 paper studies it2 findingsUpdated
See all 1 papers on seasonal influenza vaccination
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“Vaccination resulted in a significant increase in mean antibody titres to the H3N2 subunit of the vaccine.”
None of its findings points the other way.
- 1 lab in 1 country
- Funder: Biotechnology and Biological Sciences Research Council
- Human trial1
Studies in people
1 study gave seasonal influenza vaccination to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
| Randomized trial | 125 people18–35 y or 60–85 yYoung (18–35 y) and older (60–85 y) healthy adults | Immunity & ageing : I & A, Mar 15, 2016 |
What did studies of seasonal influenza vaccination find?
2Studies of seasonal influenza vaccination measured 2 outcomes: antibody response and antibody response.
Antibody response
upin humans1
1 study
Antibody response
upin humans1
Seasonal influenza vaccination increases antibody response in humans.
“Vaccination resulted in a significant increase in mean antibody titres to the H3N2 subunit of the vaccine.”
Human trialn = 125
Immunity & ageing : I & A
Antibody response
upin humans1
1 study
Antibody response
upin humans1
Seasonal influenza vaccination increases antibody response in humans.
“Vaccination resulted in a significant increase in total antibody titres, vaccine-specific IgA, IgM and IgG and seroprotection to all three subunits”
Human trial
Immunity & ageing : I & A